Back to top
more

HeartBeam (BEAT)

(Delayed Data from NSDQ)

$0.50 USD

0.50
390,800

+0.02 (4.10%)

Updated Aug 25, 2026 04:00 PM ET

After-Market: $0.50 0.00 (-0.60%) 5:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (99 out of 246)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Zacks Market Edge Highlights: Tesla, BioTelemetary, Amazon, Booking and Nike

by Zacks Equity Research

Zacks Market Edge Highlights: Tesla, BioTelemetary, Amazon, Booking and Nike

Tracey Ryniec headshot

Investing in the Innovation Winners

by Tracey Ryniec

If only an investor could buy companies that were on the cutting edge. How do you find those stocks?

Tirthankar Chakraborty headshot

U.S. Service Sector Humming: 5 Solid Buys

by Tirthankar Chakraborty

The non-manufacturing index comes in at 59.7 in February, topping analysts' estimates of 57.3. It also sees uninterrupted expansion for the 109th consecutive month.

Zacks Equity Research

BioTelemetry (BEAT) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

BioTelemetry (BEAT) delivered earnings and revenue surprises of 33.33% and 0.57%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

BioTelemetry (BEAT) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

BioTelemetry (BEAT) closed at $76.01 in the latest trading session, marking a -0.38% move from the prior day.

Zacks Equity Research

BioTelemetry (BEAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

BioTelemetry (BEAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

BioTelemetry (BEAT) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, BioTelemetry (BEAT) closed at $73.52, marking a +0.05% move from the previous day.

Zacks Equity Research

BioTelemetry (BEAT) Upgraded to Buy: Here's Why

by Zacks Equity Research

BioTelemetry (BEAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

BioTelemetry (BEAT) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research

BioTelemetry (BEAT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

BioTelemetry (BEAT) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

BioTelemetry (BEAT) closed at $72.34 in the latest trading session, marking a +0.72% move from the prior day.